Company profile: JEOL
1.1 - Company Overview
Company description
- Provider of SEM and TEM (including cryo-EM) for high-resolution imaging and analysis, mass spectrometers for protein characterization, pharmaceuticals and high-throughput screening, NMR spectrometers for molecular structure analysis, EPMA for elemental analysis and high spatial resolution imaging, and FIB systems for sample preparation, imaging and analysis; based in Peabody.
Products and services
- Mass Spectrometers: JEOL engineers high-throughput instruments used for protein characterization and pharmaceutical applications, enabling precise analyses and rapid high throughput screening across complex samples
- Scanning Electron Microscopes (SEM): JEOL architects high-resolution imaging systems that deliver detailed imaging and analysis, suitable for various research and teaching applications
- Transmission Electron Microscopes (TEM): JEOL develops cryo-EM-capable instruments for detailed imaging and analysis in life sciences and materials science, enabling structural biology investigations with transmission electron microscopy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to JEOL
Gyros Protein Technologies
HQ: United States
Website
- Description: Provider of peptide synthesizers, reagents, and bioanalysis platforms for universities, biotechnology and pharmaceutical companies, and peptide houses. Offers automated peptide synthesis systems for discovery to pre-clinical studies, Gyrolab systems for high-throughput immunoassays for impurity analysis and titer quantification, PurePep EasyClean kits for catch-and-release peptide purification, and IQ/OQ services for compliant installation and operation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gyros Protein Technologies company profile →
Ossiform
HQ: Denmark
Website
- Description: Provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ossiform company profile →
Element Biosciences
HQ: United States
Website
- Description: Provider of innovative genetic analysis tools, including the AVITI System benchtop sequencer with dual flow cell capacity; AVITI24 integrating sequencing and Teton CytoProfiling to analyze DNA, RNA, proteins, and cell morphology from a single sample; Teton Assays targeting oncology, immunology, neuroscience; Cloudbreak Freestyle Kits to streamline AVITI workflows; and Avidity Sequencing for highly accurate, efficient data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Element Biosciences company profile →
Ahura Scientific
HQ: United States
Website
- Description: Provider of rugged, ultra-compact, field-enabled optical systems for the immediate identification and authentication of liquid and solid chemical substances, serving homeland security, life sciences, industrial, and medical markets; products include handheld XRF and LIBS analyzers, portable narcotics and chemical identifiers, manufactured in the USA in an ISO 9001-certified facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ahura Scientific company profile →
Ziylo
HQ: United Kingdom
Website
- Description: Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ziylo company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for JEOL
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to JEOL
2.2 - Growth funds investing in similar companies to JEOL
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for JEOL
4.2 - Public trading comparable groups for JEOL
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →